Therefore, H19 may be a target for future strategies to overcome sorafenib resistance in HCC.23 Together, this evidence suggests that sorafenib may influence the methylation levels of cancer-related genes in HCC, which are valuable in tracing sorafenib resistance. The gene discussed is H19; the disease is hepatocellular carcinoma.